Dendritic cells, Mucosal Immunity and C-type Lectins
树突状细胞、粘膜免疫和 C 型凝集素
基本信息
- 批准号:7050592
- 负责人:
- 金额:$ 37.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-05-01 至 2010-04-30
- 项目状态:已结题
- 来源:
- 关键词:BacteroidesBacteroides gingivalisFusobacterium nucleatumStreptococcusantigen presenting cellbacterial cytopathogenic effectbiological signal transductioncarbohydrate receptordendritic cellsgenetically modified animalsgut associated lymphoid tissuehematopoietic tissuehost organism interactionhuman tissueimmunologic receptorsinflammationlaboratory mouselectinmicroarray technologymonoclonal antibodymucosal immunityoral bacteriaoral mucosaoral pharyngealphosphatidylcholinesprotein tyrosine phosphatasetissue /cell culture
项目摘要
DESCRIPTION (provided by applicant): The oral cavity, the gut-associated immune system and the skin have in residence both commensal and pathogenic bacteria. Significant progress has been made in defining how the innate immune system recognizes and responds to pathogenic bacteria via signaling through pattern recognition receptors (PRRs). However, relatively little is known about how the innate immune system responds to commensal bacteria and how encounters with commensals influence how the immune system responds to pathogens. This proposal will address this fundamental question using oral microflora and the C-type lectin receptor family as a model system. We have selected the C-type lectin family because members of this family of receptors appear to be able to both recognize and mediate either positive or negative responses to pathogens and because we have defined three new members of this family. The well-defined oral microflora is ideal for addressing this question. We have identified several new C-type lectins designated DCAL-1, DCAL-2 and DCAL-3. DCAL-2 is restricted in its expression to antigen presenting cells and has within its cytoplasmic tail an immunoreceptor tyrosine inhibitory motif (ITIM), suggesting that it functions to inhibit DC activation. We will first test if dendritic cells (DCs) are regulated differently by periopathogenic bacteria vs. commensal oral bacteria. We will compare the ability of oral flora to induce DC maturation, expression of inflammatory and non-inflammatory cytokines and chemokines, and expression of TLR and C-type lectin receptors. We predict that commensal bacteria, unlike periopathogenic bacteria, will trigger an anti-inflammatory program. Using microarrays we will test the hypothesis that pathogenic and commensal bacteria activate in DCs distinctive 'prewired signaling patterns' under the control of distinct drivers, which affect DC functions. Next we will test if DCAL-2 inhibits dendritic cell functions alters responses to periopathogenic bacteria. We will determine if certain bacteria including oral microflora bind to and signal DCs through DCAL-2. Finally we will test if DCAL-2 plays an important role in the resistance to pathogenic bacterial infection in vivo. We will prepare and then characterize DCAL-2-deficient mice and determine if these mice are more susceptible or resistant to infection by P. gingivalis as measured by alveolar bone loss and antibody responses. This work will lead to better understanding about how microflora can affect DCs.
描述(由申请人提供):口腔,肠道相关的免疫系统和皮肤在居住中均具有共生和致病性细菌。在定义先天免疫系统如何通过模式识别受体(PRR)信号传导来识别和反应致病细菌方面取得了重大进展。然而,关于先天免疫系统如何对共生细菌的反应以及与Encensals的相遇如何影响免疫系统对病原体的反应方式相对较少。该提案将使用口腔微生物和C型凝集素受体家族作为模型系统解决这个基本问题。我们选择了C型凝集素家族,因为该受体家族的成员似乎能够识别并调节对病原体的正面或负面反应,并且因为我们定义了该家族的三个新成员。定义明确的口服微生物是解决此问题的理想选择。我们已经确定了几种指定DCAL-1,DCAL-2和DCAL-3的新的C型凝集素。 DCAL-2的表达限制在抗原呈递细胞中,并在其细胞质尾部具有免疫感受器酪氨酸抑制基序(ITIM),这表明它功能抑制DC激活。我们将首先测试是否通过围栏性细菌与共生口服细菌对树突状细胞(DC)进行不同的调节。我们将比较口腔菌群诱导直流成熟,炎症和非炎性细胞因子和趋化因子的表达以及TLR和C型凝集素受体的表达的能力。我们预测,与围手术细菌不同,共生细菌将触发抗炎计划。使用微阵列,我们将测试以下假设:在不同驱动因素的控制下,DC中的致病性和共生细菌在DC独特的“前线信号传导模式”中激活,这会影响DC功能。接下来,我们将测试DCAL-2是否抑制树突状细胞功能会改变对毛细菌的反应。我们将确定包括口腔微生物(包括口腔微生物)与DCAL-2结合和信号DC的某些细菌。最后,我们将测试DCAL-2在体内对致病细菌感染的抗性中是否起重要作用。我们将准备并表征DCAL-2缺陷型小鼠,并确定这些小鼠是否更容易受到牙龈疟原虫感染的感染或抗性,这是通过肺泡骨损失和抗体反应测量的。这项工作将使人们更好地了解菌群如何影响DC。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Edward A Clark其他文献
Edward A Clark的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Edward A Clark', 18)}}的其他基金
Development of Novel CD180-Based Cancer Immunotherapeutics
基于 CD180 的新型癌症免疫疗法的开发
- 批准号:
10381384 - 财政年份:2022
- 资助金额:
$ 37.11万 - 项目类别:
Establishing and characterizing BAFF RFP reporter and BAFF knockin mice
BAFF RFP 报告基因和 BAFF 敲入小鼠的建立和表征
- 批准号:
8468991 - 财政年份:2012
- 资助金额:
$ 37.11万 - 项目类别:
Establishing and characterizing BAFF RFP reporter and BAFF knockin mice
BAFF RFP 报告基因和 BAFF 敲入小鼠的建立和表征
- 批准号:
8353277 - 财政年份:2012
- 资助金额:
$ 37.11万 - 项目类别:
Regulation of B cell responses to West Nile Virus Infections
B 细胞对西尼罗河病毒感染反应的调节
- 批准号:
7746284 - 财政年份:2009
- 资助金额:
$ 37.11万 - 项目类别:
Dendritic cells, Mucosal Immunity and C-type Lectins
树突状细胞、粘膜免疫和 C 型凝集素
- 批准号:
6852485 - 财政年份:2005
- 资助金额:
$ 37.11万 - 项目类别:
Dendritic cells, Mucosal Immunity and C-type Lectins
树突状细胞、粘膜免疫和 C 型凝集素
- 批准号:
7410149 - 财政年份:2005
- 资助金额:
$ 37.11万 - 项目类别:
Dendritic cells, Mucosal Immunity and C-type Lectins
树突状细胞、粘膜免疫和 C 型凝集素
- 批准号:
7596450 - 财政年份:2005
- 资助金额:
$ 37.11万 - 项目类别:
Dendritic cells, Mucosal Immunity and C-type Lectins
树突状细胞、粘膜免疫和 C 型凝集素
- 批准号:
7223471 - 财政年份:2005
- 资助金额:
$ 37.11万 - 项目类别:
相似国自然基金
牙龈卟啉单胞菌通过NDK调节P2X7/AMPK/mTOR途径诱导口腔癌细胞自噬、抑制焦亡促进肿瘤侵袭、转移
- 批准号:82360481
- 批准年份:2023
- 资助金额:33 万元
- 项目类别:地区科学基金项目
牙龈卟啉单胞菌通过TRIM4泛素化Lamin B/HP1α介导异染色质解聚促进口腔上皮细胞不良转归的机制研究
- 批准号:82370975
- 批准年份:2023
- 资助金额:47 万元
- 项目类别:面上项目
牙周炎中牙龈成纤维细胞分泌IL-24激活JAK1/ETS-2/NOX2通路诱导NETs形成的机制研究
- 批准号:82301065
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
菌群代谢产物TMAO激活Caspase-6/GSDME介导的牙龈上皮细胞焦亡并重塑免疫微环境在种植体周病中的作用和分子机制研究
- 批准号:82301072
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
牙龈卟啉单胞菌激活CAFs调控SDF-1/CXCR4通路促进食管癌进展及免疫逃逸的机制研究
- 批准号:82302966
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Superhydrophobic Implantable Surface and 3D Printing Technology for Targeted Dental Photodynamic Therapy
用于靶向牙科光动力治疗的超疏水植入表面和 3D 打印技术
- 批准号:
9339656 - 财政年份:2016
- 资助金额:
$ 37.11万 - 项目类别:
Superhydrophobic Implantable Surface and 3D Printing Technology for Targeted Dental Photodynamic Therapy
用于靶向牙科光动力治疗的超疏水植入表面和 3D 打印技术
- 批准号:
9254117 - 财政年份:2016
- 资助金额:
$ 37.11万 - 项目类别:
Dendritic cells, Mucosal Immunity and C-type Lectins
树突状细胞、粘膜免疫和 C 型凝集素
- 批准号:
6852485 - 财政年份:2005
- 资助金额:
$ 37.11万 - 项目类别: